Singapore-based startups Accredify and Breathonix have announced their collaboration to supply an on-site COVID-19 rapid-breath test system that issues digital verifiable COVID-19 test results compliant with countries’ international travel and domestic health requirements in less than one minute.

Accredify and Breathonix will be integrating their existing products to provide a quick, reliable, and affordable on-site solution to test an individual’s COVID-19 health status with a single breath sample.

Breathonix’s proprietary rapid breath test system, the BreFence^TM Go COVID-19 Breath Test System, will collect and analyse a patient’s breath sample through a one-way disposable MouthShield. Accredify will then issue the verifiable digital COVID-19 breathalyzer test result to the patient on location.

The rapid breath test will provide a portable and efficient COVID health screening procedure to facilitate the reopening of physical offices, schools, and events.

With Accredify, BreFence^TM Go’s digital breath test results will adhere to a country’s required COVID-19 test result schema.

As a result, Breathonix’s breathalyzer test results will be internationally recognised and can be used for verification purposes by relevant authorities for international and domestic travel.

Integration is currently underway with Breathonix’s BreFence^TM Go systems in Singapore, Malaysia, and Vietnam.

This partnership will go beyond COVID-19 as Breathonix develops breath test for other critical diseases such as early detection of lung cancer.